Custom Recombinant Protein Production Services Market 2025 custom recombinant protein production services market is estimated to be valued ...

This infographic highlights the key advantages of CHO cells and the technologies that are pushing the boundaries of cell ...

Strong revenue performance, including approximately $1.9 million milestone and license revenue recognized in 2024Up to $7.5 ...

recombinant proteins and plasmid DNA for clients across the globe - EffiX™ delivers high-yield production across multiple modalities, achieving titers of over 15 g/L for non-mAb recombinant ...

Q4 2024 Earnings Call Transcript March 26, 2025 Dyadic International, Inc. misses on earnings expectations. Reported EPS is $ ...

The Global Recombinant Chemicals Market is valued at approximately USD 2.9 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.8% over the forecast period 2024-2032.

Strong revenue performance, including approximately $1.9 million milestone and license revenue recognized in 2024Up to $7.5 million in grants awarded from CEPI and Gates Foundation intended to acceler ...

iAccess Alpha hosts virtual investor conferences featuring companies recommended by investors. These two-day events include webcast presentations on Day 1, followed by one-on-one meetings between ...

Detailed price information for Protalix Biotherapeutics (PLX-A) from The Globe and Mail including charting and trades.

A recent WHO-led study published in Vaccine provides updated estimates on the global production capacity of influenza ...

Good evening and welcome to Dyadic International's Year-End 2024 Conference Call. Currently, all participants are in a listen-only mode. Following management's prepared remarks, there will be a brief ...

Although a considerable fraction of recalcitrant proteins will still need customized production ... method could greatly increase the number of recombinant proteins available for biochemical ...